A detailed history of Brucke Financial, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Brucke Financial, Inc. holds 1,643 shares of ABT stock, worth $213,639. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,643
Previous 1,595 3.01%
Holding current value
$213,639
Previous $217 Million 6.37%
% of portfolio
0.12%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$120.51 - $136.62 $5,784 - $6,557
48 Added 3.01%
1,643 $203 Million
Q2 2025

Jul 24, 2025

BUY
$123.95 - $138.08 $4,090 - $4,556
33 Added 2.11%
1,595 $217 Million
Q1 2025

May 07, 2025

BUY
$111.1 - $140.22 $173,538 - $219,023
1,562 New
1,562 $204 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Brucke Financial, Inc. Portfolio

Follow Brucke Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brucke Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brucke Financial, Inc. with notifications on news.